Literature DB >> 22631642

Risk factors of hepatocellular carcinoma--current status and perspectives.

Jing Gao1, Li Xie, Wan-Shui Yang, Wei Zhang, Shan Gao, Jing Wang, Yong-Bing Xiang.   

Abstract

Hepatocellular carcinoma is a common disorder worldwide which ranks 5th and 7th most common cancer among men and women. In recent years, different incidence trends have been observed in various regions, but the reasons are not completely understood. However, due to the great public efforts in HCC prevention and alternation of lifestyle, the roles of some well documented risk factors played in hepatocarcinogenesis might have changed. This paper summarizes both the environmental and host related risk factors of hepatocellular carcinoma including well established risk factors such as hepatitis virus infection, aflatoxin and alcohol, as well as possible risk factors such as coffee drinking and other dietary agents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22631642     DOI: 10.7314/apjcp.2012.13.3.743

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  50 in total

1.  Association of hOGG1 Ser326Cys polymorphism with susceptibility to hepatocellular carcinoma.

Authors:  Jun Guo; Jing Yang; Yan Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 2.  A Review on Dietary and Non-Dietary Risk Factors Associated with Gastrointestinal Cancer.

Authors:  Lohith Mysuru Shivanna; Asna Urooj
Journal:  J Gastrointest Cancer       Date:  2016-09

3.  Clear Cell Cancer of the Liver Presenting with Pathological Humeral Fracture: a Case Report.

Authors:  Mina S Hanna; Debasish Das
Journal:  J Gastrointest Cancer       Date:  2015-12

4.  miRNA-708 functions as a tumour suppressor in hepatocellular carcinoma by targeting SMAD3.

Authors:  Qi Li; Sheng Li; Yaolu Wu; Feng Gao
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

5.  Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: a meta-analysis.

Authors:  Ri-Chu Zhang; Si-Hua Mou
Journal:  Tumour Biol       Date:  2012-12-28

6.  XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma susceptibility: A meta-analysis of 11 case-control studies in an Asian population.

Authors:  Q I Yang; Yan-Fei Wei; Yuan Zhang; Guang-Mei Huang
Journal:  Exp Ther Med       Date:  2015-04-14       Impact factor: 2.447

Review 7.  Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis.

Authors:  Guanghua Rong; Hong Wang; Christopher L Bowlus; Chunping Wang; Yinying Lu; Zhen Zeng; Jianhui Qu; Min Lou; Yan Chen; Linjing An; Yongping Yang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

8.  Valproic acid overcomes transforming growth factor-β-mediated sorafenib resistance in hepatocellular carcinoma.

Authors:  Yasunobu Matsuda; Toshifumi Wakai; Masayuki Kubota; Mami Osawa; Yuki Hirose; Jun Sakata; Takashi Kobayashi; Shun Fujimaki; Masaaki Takamura; Satoshi Yamagiwa; Yutaka Aoyagi
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

9.  Hepatitis B virus X stimulates redox signaling through activation of ataxia telangiectasia mutated kinase.

Authors:  Yasunobu Matsuda; Ayumi Sanpei; Toshifumi Wakai; Masayuki Kubota; Mami Osawa; Yuki Hirose; Jun Sakata; Takashi Kobayashi; Shun Fujimaki; Masaaki Takamura; Satoshi Yamagiwa; Masahiko Yano; Shogo Ohkoshi; Yutaka Aoyagi
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 10.  Mycotoxins are conventional and novel risk biomarkers for hepatocellular carcinoma.

Authors:  Yasunobu Matsuda; Toshifumi Wakai; Masayuki Kubota; Mami Osawa; Ayumi Sanpei; Shun Fujimaki
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.